Neglected disease research and development: how much are we really spending

submitted by: mparkinson
The need for new pharmaceutical tools to prevent and treat neglected diseases is widely accepted. The creation of a vaccine for HIV/AIDS, more effective diagnostics for tuberculosis (TB), and better treatments for leishmaniasis and sleeping sickness would greatly improve health in the developing world in line with the United Nations Millennium Development Goals. However, funders wishing to invest in this vitally important area currently face an information gap. There is little consensus on...
Authors: Mary Moran, Javier Guzman, Anne-laure Ropars, Alina Mcdonald, Nicole Jameson, Brenda Omune, Sam Ryan, Lindsey Wu